WHO advises against Gilead’s remdesivir for all hospitalized COVID-19 patients

Gilead’s drug remdesivir is not recommended for patients hospitalized with COVID-19, regardless of how ill they are, as there is no evidence it improves survival or reduces the need for ventilation, a World Health Organization panel said on Friday.

Latest News

Related articles